Leonteq Securities AG
Broker-DealerPosition in TVRD — Tvardi Therapeutics, Inc.
CIK 1535950
ZURICH, V8
Position in TVRD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$22
-$16 QoQ
Shares Held
12
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 58 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Leonteq Securities AG holds $31,064,274 across 57 Biotechnology names. TVRD ranks #55 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
267,131 | $18,707,183 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,948 | $2,461,735 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,433 | $2,202,004 | |
| 4 | BNTX |
BioNTech SE
|
11,461 | $1,066,446 | |
| 5 | BEAM |
Beam Therapeutics Inc.
|
27,926 | $958,420 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
2,616 | $640,318 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
150,000 | $624,000 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
15,457 | $602,977 |
All Filings in TVRD
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22 | 12 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $38 | 12 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $51 | 12 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $467 | 12 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $279 | 12 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||